JFK’s granddaughter launches a devastating public attack on her own cousin Robert F. Kennedy Jr. while revealing her terminal cancer diagnosis, exposing deep fractures within America’s most famous political dynasty.
Story Highlights
- Tatiana Schlossberg, 35, announces terminal leukemia diagnosis in scathing New Yorker essay
- Directly criticizes cousin RFK Jr.’s health policies as threat to cancer research funding
- Reveals family tensions over Kennedy Jr.’s controversial government appointment
- Warns about potential cuts to life-saving medical research under current administration
Kennedy Family Feud Goes Public
Tatiana Schlossberg used her terminal cancer announcement to launch an unprecedented family attack on Robert F. Kennedy Jr., now serving as Secretary of Health and Human Services. The environmental journalist and daughter of Caroline Kennedy disclosed her diagnosis of acute myeloid leukemia with a rare Inversion 3 mutation through a New Yorker essay that doubles as political warfare. Her public criticism exposes the bitter divisions within the Kennedy clan over RFK Jr.’s controversial anti-vaccine positions and government role.
https://abcnews.go.com/Politics/video/jfks-granddaughter-reveals-terminal-cancer-diagnosis-127788205
Medical Crisis Becomes Political Weapon
Schlossberg strategically timed her health revelation to coincide with sharp criticism of current healthcare policies. She credits advanced treatments like CAR-T therapy and stem cell transplantation for extending her life, then warns these innovations face threats under new leadership. The 35-year-old mother of two underwent treatment at Memorial Sloan Kettering, receiving a stem cell transplant from her sister before ultimately relapsing. Her essay transforms personal tragedy into ammunition against family members she views as endangering medical progress.
The diagnosis occurred shortly after childbirth two years ago, following routine blood tests that revealed the aggressive cancer. Despite achieving initial remission through cutting-edge treatments, Schlossberg’s condition deteriorated to terminal status. Her public disclosure on November 22, 2025, deliberately coincided with pointed commentary about federal health policy decisions affecting cancer research funding and women’s healthcare access.
Research Funding Under Fire
Schlossberg’s essay raises serious concerns about the future of medical research under the current administration. She specifically highlights how FDA drug review processes and research funding decisions could impact cancer patients and women’s health initiatives. Her warnings about potential cuts to public research funding strike at core conservative principles of protecting American innovation and medical excellence. The Kennedy granddaughter’s critique suggests current policies may undermine the very research infrastructure that developed her life-extending treatments.
Medical experts confirm the rarity and severity of Schlossberg’s condition, with Dr. Stephanie Widmer noting that acute myeloid leukemia with Inversion 3 is particularly aggressive in younger patients. The American Cancer Society reports rising cancer rates among Gen X and millennials, making research funding debates increasingly urgent. Schlossberg’s case exemplifies how advanced American medical research can extend lives, even in terminal cases, highlighting what’s at stake in current policy discussions.
